← Leaderboards
Adam Linn
Humanitas Inc
$754,738
Attributed
$754,738
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $385.9K · FY2016–17$500K$375K$250K$125K$0
'16
'17
Funding mix
By agency
NIH$754,738 · 2
By mechanism
N02$754,738 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cancer Therapy Evaluation Program”
- David Heimbrook · Leidos Biomedical Research, Inc.$309,543,556
- Charles A Coltman · Southwest Oncology Group$170,763,900
- Sudhir Raju · Ctis, Inc.$162,951,242
- Norman Wolmark · Nsabp Foundation, Inc.$144,396,654
- Peter J O'Dwyer · University Of Pennsylvania$121,259,702
- Larry Arthur$118,483,032
Research focus
Cancer Therapy Evaluation ProgramSoftware ToolsWeb SitePerformance